Page last updated: 2024-08-17

quinoxalines and Hereditary Optic Neuroretinopathy

quinoxalines has been researched along with Hereditary Optic Neuroretinopathy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhatti, MT; Biousse, V; Chen, K; David, R; Farris, BK; Hamilton, SR; Keaney, RP; Lesser, RL; Newman, NJ; Newman, SA; Turbin, RE	1
Bhatti, MT; Biousse, V; Farris, BK; Hamilton, SR; Lesser, RL; Newman, NJ; Newman, SA; Turbin, RE	1

Trials

2 trial(s) available for quinoxalines and Hereditary Optic Neuroretinopathy

Article	Year
Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. American journal of ophthalmology, 2005, Volume: 140, Issue:3 Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; DNA, Mitochondrial; Female; Functional Laterality; Humans; Male; Middle Aged; Mutation; Optic Atrophy, Hereditary, Leber; Pilot Projects; Premedication; Prospective Studies; Quinoxalines; Treatment Outcome; Visual Acuity; Visual Fields	2005
Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. American journal of ophthalmology, 2006, Volume: 141, Issue:6 Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optic Atrophy, Hereditary, Leber; Pilot Projects; Prospective Studies; Quinoxalines; Vision Disorders; Visual Field Tests; Visual Fields	2006

Article

Year

Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite.

American journal of ophthalmology, 2005, Volume: 140, Issue:3

Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; DNA, Mitochondrial; Female; Functional Laterality; Humans; Male; Middle Aged; Mutation; Optic Atrophy, Hereditary, Leber; Pilot Projects; Premedication; Prospective Studies; Quinoxalines; Treatment Outcome; Visual Acuity; Visual Fields

2005

Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.

American journal of ophthalmology, 2006, Volume: 141, Issue:6

Topics: Administration, Topical; Adolescent; Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optic Atrophy, Hereditary, Leber; Pilot Projects; Prospective Studies; Quinoxalines; Vision Disorders; Visual Field Tests; Visual Fields

2006